Expanding telehealth is a very important way to overcome disparities in healthcare access. Bill to extend telehealth flexibilities clears House committee ama-assn.org/practice-manag… (via AMA)

Our new paper is out nature We report that fibrin drives toxic inflammation, impaired viral clearance & neuropathology in #SARSCoV2 infection treated by #fibrin antibody #LongCovid #Coagulation #Immunotherapy #fibrinogen #COVID19 nature.com/articles/s4158…

Make your #ASCOAdvocacy voices heard via ASCO ACT Network and join your state affiliate! asco.org/actnetwork

🗳️ Are you a US citizen & ASCO member who is interested in the future of cancer care in our country? 🗳️ Please consider joining me in donating to the ASCO Association PAC (a nonpartisan PAC) 🗳️ Read below…. 🗳️ Click here to join: pac.ascoassociation.org

One of our biggest challenges in advancing therapies for cancer is low participation in clinical trials. So many misconceptions and so little access. All new drugs available today came through trials years ahead of commercial availability. #clinicaltrials Sarah Cannon Docs

#FridayNightLights Battle Ground Academy #sisters

No joy like the joy of a 7 year old who made her own glow in the dark slime.

Love this- amazing job and love the audience response! Way to go Samual!

Great preview of what's to come by Paolo Tarantino at #ESMO24 this year in #bcsm

Fun times

Dear Colleagues, The OncoAlert 🚨Network Presents OUR Picks of TOP 🔟Abstracts to be Presented at #ESMO24 This List Curated by: #OncoAlertAF Leads Elisa Agostinetto 🇮🇹 Elisabetta Bonzano MD, PhD 🇮🇹 Luca Arecco, MD 🇮🇹 Gil Morgan, MD 🇺🇸 With our distinguished OncoAlert Faculty: Sara Tolaney

Happy to be on the panel for FDA Oncology / ASCO joint workshop on measuring reproductive toxicity during oncology drug development. Open to the public! Measuring Toxicity in Reproductive Organs During Oncology Drug Development: An FDA - ASCO Workshop - 10/01/2024 | FDA

#ESMOAmbassadors #ESMO24 See you all next week!

What a lineup of great colleagues as #ESMOAmbassadors! Only 1 week before ESMO - Eur. Oncology #ESMO24 in Barcelona! Finishing posters, presentations, adding meetings, & can’t wait for new data improving cancer outcomes! Petros Grivas Erika Hamilton, MD Vivek Subbiah, MD Stephen V Liu, MD Jarushka Naidoo

Very sad how this will mislead. There is a big difference between invasive cancer & the precursor, DCIS. Chemo is not recommended or indicated for DCIS. Surgery was curative, not changes in diet or other therapies. Very dangerous when medical facts aren't accurately portrayed.

Such a productive day with so many fantastic #EducationTrack leaders for #ASCO25. The program they are putting together with Cardinale B. Smith looks absolutely fantastic! Now to continue work on the scientific program! 💪🏼 ASCO Robin Zon, MD, FACP, FASCO Thomas LeBlanc, MD, MA, MHS, FAAHPM, FASCO Erika Ruiz-Garcia

Incredible day ASCO HQ w Dr. Cardinale B. Smith leading as #ASCO25 Education Chair. Thank you to Cardi & the track leaders for your thoughtfulness, intentionality and leadership in helping Drive Knowledge to Action! Next up: #ASCO25 science under the leadership of Dr. Erika Hamilton, MD!

New recommendation for annual pancreatic cancer screening for people >50 years old with pathogenic ATM and BRCA mutations. #bcsm #gyncsm #survivorship #BRCA #ATM

Who is ready for #ESMO24? My journey has begun! Eager for the meetings, collaborations, and scientific advancements we will all share at this meeting. #ESMOAmbassadors #bcsm ESMO - Eur. Oncology

How cool ESMO - Eur. Oncology - Twitter/X list enables you to follow the #ESMOAmbassadors across all disciplines with one click for the latest presentations and news from #ESMO24. Link below! 👇🏼